Goldline Pharmaceutical IPO Description – Incorporated in 2004, Goldline Pharmaceutical is engaged in the business of marketing pharmaceutical products under its proprietary brand “Goldline.” Operating through an asset-light business model, Goldline focuses on marketing, distribution, and supply chain management, while the manufacturing of its products is outsourced to 15 third-party manufacturers under contractual arrangements that ensure compliance with WHO-GMP and ISO standards.
Goldline’s diverse product portfolio is organized into five strategic segments — Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness — comprising nearly 146 products catering to multiple medical specialties, including cardiology, neurology, gastroenterology, pediatrics, and oncology wellness. The company maintains a robust distribution network through 7 major distributors, primarily catering to wholesalers, who account for over 99% of its total sales.
Maharashtra and Madhya Pradesh together contribute over 76% of total sales, with the top five customers accounting for 78.36% of revenue, demonstrating strong client relationships and concentration in key markets. As of 31 August 2025, Goldline Pharmaceutical had a total workforce of 99 employees.
Promoters of Goldline Pharmaceutical – Amol Laxmikant Mujumdar and Swapan Premprakash Khandelwal
Goldline Pharmaceutical IPO Details
| Goldline Pharmaceutical IPO Dates | 12 – 14 May 2026 |
| Goldline Pharmaceutical Issue Price | INR 41 – 43 per share |
| Fresh Issue | 27,00,000 shares (INR 11.07 – 11.61 crore) |
| Offer For Sale | Nil |
| Total IPO Size | 27,00,000 shares (INR 11.07 – 11.61 crore) |
| Minimum Bid | 6,000 shares (INR 2,58,000) |
| Lot Size | 3,000 shares (INR 1,29,000) |
| Face Value | INR 10 per share |
| Individual Allocation | 35% |
| Listing On | BSE SME |
Goldline Pharmaceutical Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 19.85 | 23.57 | 28.06 |
| Expenses | 19.45 | 21.04 | 24.20 |
| Net income | 0.26 | 1.81 | 2.83 |
Goldline Pharmaceutical Offer News
Goldline Pharmaceutical Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 | |
| EPS | 0.43 | 3.01 | 4.11 |
| PE ratio | – | – | 9.98 – 10.46 |
| RONW (%) | 4.36 | 22.96 | 27.38 |
| NAV | 6.81 | 10.09 | 12.39 |
| ROCE (%) | 19.43 | 32.41 | 38.46 |
| EBITDA (%) | 11.06 | 18.26 | 20.79 |
| Debt/Equity | 3.09 | 2.14 | 1.50 |
Goldline Pharmaceutical IPO GMP Today
Goldline Pharmaceutical IPO Subscription – Live Updates
Coming soon
The market maker reservation portion of () shares and the anchor investor portion of () shares are not included in the above calculations.
Goldline Pharmaceutical IPO Allotment Status
Goldline Pharmaceutical IPO allotment status will be available on the Bigshare Services website. Click on this link to get the allotment status.
Goldline Pharmaceutical IPO Dates & Listing Performance
| IPO Opening Date | 12 May 2026 |
| IPO Closing Date | 14 May 2026 |
| Finalization of Basis of Allotment | 15 May 2026 |
| Initiation of refunds | 18 May 2026 |
| Transfer of shares to demat accounts | 18 May 2026 |
| IPO Listing Date | 19 May 2026 |
| Opening Price on BSE SME | Coming soon |
| Closing Price on BSE SME | Coming soon |
Goldline Pharmaceutical Offer Lead Manager
CUMULATIVE CAPITAL PRIVATE LIMITED
321, 3rd Floor, C Wing, 215 Atrium Co Op. Premises,
Andheri Kurla Road, Hanuman Nagar, Andheri (E), Mumbai – 400 093
Phone: +91 9819662664/7016251158
Email: [email protected]
Website: www.cumulativecapital.group
Goldline Pharmaceutical Offer Registrar
BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali Caves Road,
Andheri (East) Mumbai – 400 093
Tel: +91 22 6263 8200
E-mail: [email protected]
Website: www.bigshareonline.com
GOLDLINE PHARMACEUTICAL LIMITED
103, F-1, Leela Apartment, Shilpa HSG Society,
Near Saptagiri Nagar, Shanidham, Narendra Nagar, Nagpur – 440 015
Phone: +91 712 278 6666
E-mail: [email protected]
Website: www.goldlinepharma.in
IPO FAQs
What is the Goldline Pharmaceutical offer size?
Goldline Pharmaceutical offer size is INR 11.07 – 11.61 crores.
What is the Goldline Pharmaceutical offer price band?
Goldline Pharmaceutical public offer price is INR 41 – 43 per share.
What is the lot size of the Goldline Pharmaceutical IPO?
Goldline Pharmaceutical offer lot size is 3,000 shares.
What is the Goldline Pharmaceutical IPO GMP today?
Goldline Pharmaceutical IPO GMP today is INR NA per share.
What is the Goldline Pharmaceutical kostak rate today?
Goldline Pharmaceutical kostak rate today is INR NA per application.
What is the Goldline Pharmaceutical IPO Subject to Sauda rate today?
Goldline Pharmaceutical Subject to Sauda rate today is INR NA per application.
Mahesh Yadav is a prolific writer with over a decade of professional experience. A person of wide interests, he found his true calling in the field of investing and specifically the stock market. He has an amazing skill of presenting the most complex financial concepts (and there is no shortage of complexity in investing) in simple language and terms.
